India widens cancer drug price caps, cutting prices on 137 medicines

India's government has expanded price controls on cancer medications, lowering prices across 137 drug formulations. The move aims to improve affordability and accessibility of oncology treatments across the nation.

The intervention signals continued regulatory focus on pharmaceutical pricing in emerging markets, with potential implications for global drugmakers' revenue in the region.